• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种抗人铁蛋白单克隆抗体在各种免疫测定中的应用。

Applications of a monoclonal antibody to human ferritin in various immunoassays.

作者信息

Lee C Y, Leung W Y, Tung J K

出版信息

Biotechnol Appl Biochem. 1987 Feb;9(1):31-8.

PMID:3551994
Abstract

Monoclonal antibodies to human liver ferritin were generated by an improved hybridoma technique using a semisolid medium containing methylcellulose for initial cloning after the cell fusion. Out of more than 1000 hybrid clones, only 1 was shown to secrete high-affinity monoclonal antibodies to human liver ferritin. The immunoglobulin subclass of this antibody was determined to be IgG2. The association constant between liver ferritin and this antibody was determined to be greater than 1 X 10(10) M-1. Due to the oligomeric nature of ferritin, this antibody can be simultaneously utilized as the first and second antibody in solid-phase sandwich immunoradiometric and enzyme immunoassays. This immunoassay procedure can be performed within 30-45 min and has a sensitivity of about 1 ng/ml. Under identical assay conditions, ferritin isolated from human spleen and human heart gave 50 and 30% cross-reactivity, respectively.

摘要

采用改良的杂交瘤技术,使用含有甲基纤维素的半固体培养基在细胞融合后进行初始克隆,从而制备出了抗人肝铁蛋白的单克隆抗体。在1000多个杂交克隆中,只有1个被证明能分泌抗人肝铁蛋白的高亲和力单克隆抗体。该抗体的免疫球蛋白亚类被确定为IgG2。肝铁蛋白与该抗体之间的结合常数被确定大于1×10(10) M-1。由于铁蛋白的寡聚性质,该抗体可同时用作固相夹心免疫放射测定法和酶免疫测定法中的第一抗体和第二抗体。该免疫测定程序可在30 - 45分钟内完成,灵敏度约为1 ng/ml。在相同的测定条件下,从人脾脏和人心脏分离的铁蛋白的交叉反应率分别为50%和30%。

相似文献

1
Applications of a monoclonal antibody to human ferritin in various immunoassays.一种抗人铁蛋白单克隆抗体在各种免疫测定中的应用。
Biotechnol Appl Biochem. 1987 Feb;9(1):31-8.
2
Generation of monoclonal antibodies to human prolactin and applications in solid-phase immunoassays.抗人催乳素单克隆抗体的产生及其在固相免疫测定中的应用。
Biotechnol Appl Biochem. 1987 Feb;9(1):58-65.
3
Applications of monoclonal antibodies in solid-phase immunoassays of human luteinizing hormone.单克隆抗体在人促黄体生成素固相免疫测定中的应用。
J Appl Biochem. 1985 Apr;7(2):114-21.
4
Generation and epitope analysis of thyroid stimulating hormone-specific monoclonal antibodies for enzyme immunoassays.用于酶免疫测定的促甲状腺激素特异性单克隆抗体的产生及表位分析
Biotechnol Appl Biochem. 1988 Apr;10(2):137-42.
5
Generation of monoclonal antibodies to human chorionic gonadotropin by a facile cloning procedure.通过一种简便的克隆程序生成抗人绒毛膜促性腺激素的单克隆抗体。
J Appl Biochem. 1984 Feb-Apr;6(1-2):48-55.
6
Studies of monoclonal antibodies against human chorionic gonadotropin. II. Applications of human chorionic gonadotropin monoclonal antibodies on immunoassays.抗人绒毛膜促性腺激素单克隆抗体的研究。II. 人绒毛膜促性腺激素单克隆抗体在免疫测定中的应用。
Diagn Immunol. 1986;4(4):194-200.
7
[Production and clinical study of monoclonal antibodies against liver ferritin].[抗肝铁蛋白单克隆抗体的制备及临床研究]
Gan No Rinsho. 1986 Aug;32(9):987-91.
8
Enzyme-linked immunosorbent assay for canine serum ferritin, using monoclonal anti-canine ferritin immunoglobulin G.使用单克隆抗犬铁蛋白免疫球蛋白G的犬血清铁蛋白酶联免疫吸附测定法。
Am J Vet Res. 1988 Jul;49(7):1193-5.
9
[Analysis of various isoferritins with monoclonal antibodies].[用单克隆抗体分析各种异铁蛋白]
C R Seances Acad Sci III. 1982 Oct 18;295(6):443-8.
10
[Monoclonal antibodies to human spleen ferritin. I. Preparation and study of the interaction with isoferritin and apoferritin].[抗人脾铁蛋白单克隆抗体。I. 与异铁蛋白和脱铁铁蛋白相互作用的制备与研究]
Biokhimiia. 1993 May;58(5):745-58.

引用本文的文献

1
Performance and comparability of laboratory methods for measuring ferritin concentrations in human serum or plasma: A systematic review and meta-analysis.用于测量人血清或血浆中铁蛋白浓度的实验室方法的性能和可比性:系统评价和荟萃分析。
PLoS One. 2018 May 3;13(5):e0196576. doi: 10.1371/journal.pone.0196576. eCollection 2018.
2
Production and characterization of a murine monoclonal antibody against human ferritin.一种抗人铁蛋白小鼠单克隆抗体的制备与鉴定
Avicenna J Med Biotechnol. 2013 Oct;5(4):212-9.